Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$34K Buy
1,329
+714
+116% +$19.8K ﹤0.01% 7315
2014
Q2
$17K Sell
615
-20
-3% -$548 ﹤0.01% 8280
2014
Q1
$19K Sell
635
-825
-57% -$22.1K ﹤0.01% 8168
2013
Q4
$37K Sell
1,460
-50
-3% -$1.25K ﹤0.01% 7362
2013
Q3
$36K Buy
1,510
+1,132
+299% +$28.3K ﹤0.01% 7293
2013
Q2
$8K Buy
+378
New +$8.15K ﹤0.01% 8870

Other funds holding TBI

UBS's TBI Position: Q3 2014 in Review

UBS increased its Trueblue (TBI) stake by 116% in Q3 2014, buying an estimated $19.8K and bringing the position to 1,329 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #7315.

UBS first reported a position in TBI in Q2 2013 and has held it in 6 quarters since. The position peaked at $37K in Q4 2013. 163 funds tracked by Wall St. Rank hold TBI as of Q3 2014.

  • UBS held 1,329 shares of Trueblue worth $34K as of Q3 2014.
  • UBS bought 714 Trueblue shares in Q3 2014, an estimated $19.8K.
  • Trueblue made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7315 holding.
  • UBS first reported a position in Trueblue in Q2 2013 and has held it in 6 quarters since.
  • UBS's Trueblue position peaked at $37K in Q4 2013.
  • 163 funds tracked by Wall St. Rank held Trueblue as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.